Trial Profile
First in human single-ascending dose study to assess Safety, Pharmacokinetic, and the effect of food on ASP8062
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 10 Oct 2018
Price :
$35
*
At a glance
- Drugs ASP 8062 (Primary)
- Indications Fibromyalgia
- Focus Adverse reactions; First in man; Pharmacodynamics; Pharmacokinetics
- 16 Sep 2018 Results assessing Safety, Tolerability, Pharmacokinetic Profile, and Pharmacodynamic Effects of ASP8062 in three phase I studies (n=108) presented at the 17th World Congress on Pain
- 27 Mar 2018 New trial record
- 24 Mar 2018 Results from two phase I studies assessing safety and pharmacokinetic profile of ASP8062 after single or multiple doses presented at the 119th Annual Meeting of the American Society for Clinical Pharmacology and Therapeutics